https://kenes-exhibitions.com/biomed2019/blog/united-therapeutics-pens-216m-deal-to-buy-steadymed-neutralizing-pump-based-threat-to-pah-franchise/
United Therapeutics pens $216M deal to buy SteadyMed, neutralizing pump-based threat to PAH...
Nov 19, 2018 - United #Therapeutics has struck a $216 million deal to buy #SteadyMed. The acquisition enables United to eliminate a potential threat by taking control of a...
https://stmedgroup.com/
Steadymed